Evidence map›Paper›PMID 36467541›Full record

ArticleMatrix biology plus2022

Small molecule inhibitors of mammalian glycosylation.

Karim Almahayni, Malte Spiekermann, Antonio Fiore, Guoqiang Yu, Kayvon Pedram, Leonhard Möckl

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Matrix biology plus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The Intersection of Glycosylation and Ferroptosis in Cancer.Antioxidants (Basel, Switzerland) · 2025
    Review
  10. Effect ofJournal of microbiology and biotechnology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The glycocalyx: Pathobiology and repair.Matrix biology plus · 2023
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Karim AlmahayniMax Planck Institute for the Science of Light, 91058 Erlangen, Germany.
Malte SpiekermannMax Planck Institute for the Science of Light, 91058 Erlangen, Germany.
Antonio FioreJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Guoqiang YuJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Kayvon PedramJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Leonhard MöcklMax Planck Institute for the Science of Light, 91058 Erlangen, Germany.
Janelia Research Campus · USMax Planck Institute for the Science of Light · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycans are one of the fundamental biopolymers encountered in living systems. Compared to polynucleotide and polypeptide biosynthesis, polysaccharide biosynthesis is a uniquely combinatorial process to which interdependent enzymes with seemingly broad specificities contribute. The resulting intracellular cell surface, and secreted glycans play key roles in health and disease, from embryogenesis to cancer progression. The study and modulation of glycans in cell and organismal biology is aided by small molecule inhibitors of the enzymes involved in glycan biosynthesis. In this review, we survey the arsenal of currently available inhibitors, focusing on agents which have been independently validated in diverse systems. We highlight the utility of these inhibitors and drawbacks to their use, emphasizing the need for innovation for basic research as well as for therapeutic applications.

Indexed as

GlycansGlycocalyxGlycosylationInhibitorsSmall molecules

Identifiers

PMID36467541
PMCPMC9713294
OpenAlexW4220940295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.